Metraipolis › archive › dc_c29df454dc0b

Targeting CXCR1/2 suppresses TH2/TH17 cell responses and inhibits dual-pathology allergic lung inflammation — Europe PMC PMID:42222593

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42222593
DOI
10.1016/j.jacig.2026.100726
License (as archived)
solo-consultazione
Archived
2026-11-02T23:46:28.022Z
SHA-256 of the archived text
da4b17edfc24d624ff10086903f7e655453488c0555498ae2001e40a7e85a261
Stable URL of this page
https://metraipolis.com/documento/dc_c29df454dc0b

How to cite

Targeting CXCR1/2 suppresses TH2/TH17 cell responses and inhibits dual-pathology allergic lung inflammation — Europe PMC PMID:42222593 — Europe PMC (en), https://europepmc.org/article/MED/42222593 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c29df454dc0b (Metraipolis archive dc_c29df454dc0b, sha256 da4b17edfc24d624ff10086903f7e655453488c0555498ae2001e40a7e85a261)
BibTeX
@misc{dcc29df454dc0b,
  title = {Targeting CXCR1/2 suppresses TH2/TH17 cell responses and inhibits dual-pathology allergic lung inflammation — Europe PMC PMID:42222593},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42222593},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c29df454dc0b; sha256 da4b17edfc24d624ff10086903f7e655453488c0555498ae2001e40a7e85a261},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222593. Agents can read the archived copy with the MCP tool read_document.